Author Archive

Is SOT For Lyme & Tick-borne Infections a Scam?

https://www.treatlyme.net/guide/sot-lyme-treatment

Is SOT for Lyme & Tick-borne Infections a Scam?

SOT for Lyme Image from Marty Ross MD
By Dr. Marty Ross

Updated: 9/19/23

This update includes a review of research published by the manufacturer of Lyme SOT in late 2022. Based on my review of this new science, I have retitled this article: Is SOT for Lyme & Tick-borne Infections a Scam?

Probability of Health Improvement

  • My clinical experience: not enough experience to say
  • MyLymeData: no research conducted
  • RGCC Funded Research: biased study with inadequate data
  • Placebo effect benefit of any prescription medicine: 30-40 percent

For more information about the best research-supported germ killing approaches to recover from Lyme disease see What Works? Navigating Prescription & Alternative Medicine Lyme Treatments.

Supportive Oligonucleotide Therapy Background

Supportive Oligonucleotide Therapy (SOT) is a new treatment for Lyme disease. SOT is also called Antisense Oligonucleotide Therapy (ASOT), which is the term used in medical research papers. SOT uses laboratory-derived nucleic acids (genetic code) that blocks production of disease-causing proteins or even gene expression. These pieces of genetic code are called oligonucleotides. You can think of oligonucleotides as a genetic message.

For example, in Duchenne muscular dystrophy (DMD), SOT provides oligonucleotides to direct the correct production of a protein called dystrophin. People with muscular dystrophy are born with DNA that provides the wrong genetic message for dystrophin. SOT correction to the DNA message leads to production of dystrophin. This prevents the muscle damage seen in DMD.

In Lyme disease, a currently available type of SOT produced by RGCC in Greece uses oligonucleotides to stop germ growth and replication. Unlike the SOT therapy for DMD, the Lyme SOT is not an FDA-approved drug. To be approved by the FDA, a therapy must have scientific evidence of safety and effectiveness.

As I explain below, SOT does not alter DNA. Instead, it provides a short-term change to how the DNA blueprint is expressed.  (See link for article)

For more:

A Personal Journey of Healing Body, Mind, and Spirit

https://www.lymedisease.org/erin-leopold-personal-journey/

A personal journey of healing body, mind, and spirit

By Erin Leopold

Aug. 23, 2023

I am listening, but it’s as if I am under water and everything they are saying is garbled and unclear. All I can think is, how do I have Lyme disease when I am sure I was tested several different times? Is this what I suffered with since I first got sick at age 17?

Despair and hopelessness flood my veins. Anger at how this wasn’t caught storms my mind. I am furious at all these doctors over the years who made me feel like I was crazy and that it’s all in my head! All the looks and comments from them implying I needed to see a shrink. NO! I trusted doctors to know what they were doing and help me but instead I faced continual dismissal like I was some hypochondriac. I am mad, and I’m not alone.

My name is Erin Leopold, and the above is an excerpt from my recently released memoir entitled Finding My Second Wind. My story begins as a 17-year-old high school junior making good grades, enjoying life with family and friends, and playing high-level soccer. I was the picture of health and resembled the All-American girl.

Suddenly, my life changed for the worse when I became extremely ill from an otherwise common childhood virus. It wasn’t long before life as I knew it came to a screeching halt as physical debilitation set in. I was also overcome with fear and anxiety.

Finding the root cause

Lyme disease and co-infections played a significant role in my life for 32 years, proving to be at the root of my 20+ medical diagnoses. I had SO many symptoms throughout these exhausting years: GI issues including numerous food allergies/intolerances; musculoskeletal pain including degenerative discs/stenosis/sciatica (led to two surgeries); severe outdoor allergies leading to chronic sinus infections; dizziness; brain fog; profuse sweating; weakness/neuropathy; anxiety; depression; confusion; burning and numbness in my extremities; migraines; insomnia; adrenal fatigue; and hormonal imbalances.

I used a balanced approach to treatment, leaning more towards functional/integrative medicine because allopathic medicine sought to treat symptoms only, and I desired a more holistic approach addressing root causes. I became my greatest advocate by voraciously studying all things nutrition and lifestyle changes. I did everything from taking an abundance of supplements and herbs to massage therapy, chiropractic care, infrared saunas, acupuncture, dry needling, active release/myofascial release, reiki, electromagnet shields/mattresses/shoe inserts, and detox baths. You name it and I probably did it.

Now, I am 54 and have been married for 30 years. I am a mom to three adult children and two fur babies. I love nature and the outdoors and have spent most of my life leading and teaching people through fitness and health.

Healing, finally

Like many of you reading this, I’ve gone through many ups and downs, victories and defeats. Yet things finally came together for me.

After years of treatments,  I began working to heal my soul and learned a lot about neuroplasticity and how the mind works. Dots started connecting. My faith is the cornerstone to that success as I began studying and meditating on the Word of God along with doing other reading/learning/therapies including transformational prayer, EMDR, DNRS, and works by top doctors in the neuroscience/brain field. It’s like one day I woke up and breakthroughs came!

Finding My Second Wind chronicles my personal journey of healing the spirit, soul, and body. If you find yourself running on a similar, unplanned road, I hope my story will equip you with useful tools and motivate you to never give up.

Erin Leopold lives in South Carolina. Click here for more information about her book.

For more:

I could literally go onto infinity with these stories.  Unfortunately, while they help the public understand things better, they don’t appear to make one iota of difference in the medical field or in research.  Forty years have passed with little to no progress.  Patients are still mis or undiagnosed, untreated, suffer horrifically, and get ZERO help in mainstream medicine or most research.  Again, your best help will come from the maligned Lyme literate doctors who are continually persecuted by state medical boards.

Autoimmune Inflammatory Reactions in Terminally Differentiated Tissues & Inability to Work Following COVID Shots – A Relevant Aspect For Future Boosters

https://www.researchgate.net/publication/373925710_Autoimmune_inflammatory_reactions_triggered_by_the_COVID19_genetic_vaccines_

Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues

Abstract

As a result of the spread of SARS-CoV-2, a global pandemic was declared. Indiscriminate COVID-19 vaccination has been extended to include age groups and naturally immune people with minimal danger of suffering serious complications due to COVID-19. Solid immuno-histopathological evidence demonstrates that the COVID-19 genetic vaccines can display a wide distribution within the body, affecting tissues that are terminally differentiated and far away from the injection site. These include the heart and brain, which may incur in situ production of spike protein eliciting a strong autoimmunological inflammatory response. Due to the fact that every human cell which synthesises non-self antigens, inevitably becomes the target of the immune system, and since the human body is not a strictly compartmentalised system, accurate pharmacokinetic and pharmacodynamic studies are needed in order to determine precisely which tissues can be harmed. Therefore, our article aims to draw the attention of the scientific and regulatory communities to the critical need for biodistribution studies for the genetic vaccines against COVID-19, as well as for rational harm-benefit assessments by age group.
Numerous studies report the onset of autoimmune reactions following COVID-19 vaccination [47, 59-76]. The histopathological data provide indisputable evidence that demonstrates that the genetic vaccines exhimbit an off-target distribution, causing the synthesis of the spike protein and thus triggering autoimmune inflammatory reactions, even in tissues which are terminally differentiated and subject to symptomatic damage [38-40, 42].
______________________
The conclusions are inescapable, mRNA vaccines will cause autoimmunity in all applications. The human body is simply too good at recognizing foreign proteins that populate at the cell surface synthesized from mRNA on ribosomes in the Golgi complex. ~ Dr. Peter McCullough

https://pubmed.ncbi.nlm.nih.gov/37562083/

Inability to work following COVID-19 vaccination-a relevant aspect for future booster vaccinations

PMID: 37562083

DOI: 10.1016/j.puhe.2023.07.008

Abstract

Objectives: COVID-19 vaccination is a key prevention strategy to reduce the spread and severity of SARS-CoV-2 infections. However, vaccine-related inability to work among healthcare workers (HCWs) could overstrain healthcare systems.

Study design: The study presented was conducted as part of the prospective CoVacSer cohort study.

Methods: This study examined sick leave and intake of pro re nata medication after the first, second, and third COVID-19 vaccination in HCWs. Data were collected by using an electronic questionnaire.

Results: Among 1704 HCWs enrolled, 595 (34.9%) HCWs were on sick leave following at least one COVID-19 vaccination, leading to a total number of 1550 sick days. Both the absolute sick days and the rate of HCWs on sick leave significantly increased with each subsequent vaccination. Comparing BNT162b2mRNA and mRNA-1273, the difference in sick leave was not significant after the second dose, but mRNA-1273 induced a significantly longer and more frequent sick leave after the third.

Conclusion: In the light of further COVID-19 infection waves and booster vaccinations, there is a risk of additional staff shortages due to post vaccination inability to work, which could negatively impact the already strained healthcare system and jeopardize patient care. These findings will aid further vaccination campaigns to minimize the impact of staff absences on the healthcare system.

For more:

See Twitter link to enlarge graph

Contact Your Senators: Exit the WHO

https://jamesroguski.substack.com/p/contact-your-senators?

Share this link: http://Senate.ExitTheWHO.com

As of September 14, 2023, 50+ members of the House of Representatives have signed on as co-sponsors of the WHO Withdrawal Act (H.R.79). Details: ExitTheWHO.com

HOWEVER, NOT EVEN ONE SENATOR has shown the courage to simply copy H.R. 79 and submit it as companion legislation in the Senate.

NOT ONE SENATOR

Please go to stop link for your Senator’s information and then email them the following information or call and state the following:

BASIC TEXT VERSION:

Simply copy the text below, scroll down and click on the contact links for both of your Senators, paste the text into their contact form and send them an email.

Dear Senator,

I want the United States to #ExitTheWHO. 

I want you to submit companion legislation in the Senate in support of House Resolution 79, the

World Health Organization Withdrawal Act.

The sponsor of this legislation, Representative Andy Biggs (AZ-05) has already gained the support of 50+ co-sponsors in the House who also support the United States’ withdrawal from the World Health Organization.

I want you to simply copy H.R. 79 and submit it as a companion bill in the Senate as soon as possible.

Sincerely,

One more American that wants to #ExitTheWHO.

_______________

http://  Approx. 10 Min

Get Out of the W.H.O

James Roguski lays out the plan for victory in the U.S. Senate. We need more co-sponsors of the Biggs bill (H.R. 79) which would get the U.S. out of the world health organization.

Please also read ‘Creating a Digital Prison’: WHO Rushes Ahead on Global Digital Health Certificates,” and ‘All Eyes on the WHO’: Critics Warn of Power Grab on Eve of UN Pandemic Declaration Vote.

For more:

Study: Oral NAD+ & NMN Increases Intracellular NAD+ & Lowers Triglycerides

https://www.townsendletter.com/e-letter-17-nad_plus-supplementation-and-cellular-energy/

Case Study: Oral Supplementation with the NAD+ Precursor Nicotinamide Mononucleotide (NMN)—Effects on Intracellular NAD+ and Triglycerides.

Alan Miller, ND

Abstract

NAD+ is a coenzyme that is essential in numerous metabolic reactions, the most important involving energy production. In the cellular respiration process, NAD+ is required for the production of ATP (adenosine triphosphate), the primary energy currency of cells. NAD+ transfers electrons from molecules including glucose during glycolysis and the citric acid cycle. These electrons are then transferred to the electron transfer chain, where NAD+ acts as an essential mediator in energy production, ensuring the efficient functioning of cells. NAD+ is also critically involved in DNA repair and healthy aging sirtuin enzymes.

Nicotinamide Mononucleotide (NMN) is the most direct biochemical precursor to NAD+ and thus supplementation of this molecule is an efficient method of increasing intracellular NAD+, which can improve cellular energetics and markers of aging. NMN may also lower triglycerides. In a study of intravenous dosing of 300 mg NMN in 10 healthy individuals, researchers discovered a significant reduction in serum triglycerides.

One concern with NMN is that when taken in an oral dose this molecule might be damaged or otherwise metabolized by stomach acid, pancreatic enzymes, or first pass hepatic enzymes. In other studies, we have shown that a liposomal powder preparation can protect other molecules, such as glutathione, from this type of degradation and significantly increase blood levels of the whole molecule.

We performed a small case study in which individuals were given 1000 mg of an oral liposomal NMN preparation (powder in a capsule) once after a baseline blood test. Serial triglyceride tests were performed hourly for five hours. Participants had an average of 15% decrease in triglycerides at hour five, compared to baseline. Another group was tested at baseline for intracellular NAD+ (Jinfinity Labs), then was given 1000 mg of a liposomal powder NMN daily for 15 days. An intracellular NAD+ test was then performed after 15 days. NAD+ levels increased 100 percent over this period.

This is the first case series that has demonstrated a rapid triglyceride-lowering effect of oral liposomal NMN (over 5 hours), along with a 100-percent increase in intracellular NAD+ over a 15-day period.

(See link for full article)

For more: